ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.802,06
-0,19%
S&P 500
5.291,34
0,15%
US Dollar vs BRL
5,2892
0,00%
Bitcoin
71.016,48
0,64%
Brent Oil
77,455
0,45%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Gelesis Holdings Inc (GLS)

  7. Gelesis Holdings Inc (GLS) Notícias

GLS

Gelesis (GLS)

Gelesis Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:GLS
DataHoraFonteTítuloCódigoCompanhia
30/10/202321:58Edgar (US Regulatory)Form 8-K - Current reportNYSE:GLSGelesis Holdings Inc
07/09/202317:03Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNYSE:GLSGelesis Holdings Inc
24/07/202322:47Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNYSE:GLSGelesis Holdings Inc
29/06/202317:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NYSE:GLSGelesis Holdings Inc
29/06/202317:03Edgar (US Regulatory)Current Report Filing (8-k)NYSE:GLSGelesis Holdings Inc
26/06/202318:27Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:GLSGelesis Holdings Inc
14/06/202317:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:GLSGelesis Holdings Inc
15/05/202317:46Edgar (US Regulatory)Quarterly Report (10-q)NYSE:GLSGelesis Holdings Inc
26/04/202311:13Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NYSE:GLSGelesis Holdings Inc
03/04/202317:05GlobeNewswire Inc.Sight Sciences Appoints Ali Bauerlein as Chief Financial OfficerNYSE:GLSGelesis Holdings Inc
31/03/202307:19Edgar (US Regulatory)Notice of Effectiveness (effect)NYSE:GLSGelesis Holdings Inc
28/03/202318:17Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NYSE:GLSGelesis Holdings Inc
28/03/202308:00Business WireGelesis Reports Fourth Quarter and Full Year 2022 ResultsNYSE:GLSGelesis Holdings Inc
27/03/202317:07Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NYSE:GLSGelesis Holdings Inc
03/03/202314:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NYSE:GLSGelesis Holdings Inc
14/02/202308:10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:GLSGelesis Holdings Inc
05/01/202309:00Business WireGelesis to Participate in the 25th Annual ICR ConferenceNYSE:GLSGelesis Holdings Inc
30/12/202218:31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NYSE:GLSGelesis Holdings Inc
21/11/202209:00Business WireGelesis Reports Upcoming Participation in Wolfe Research’s Annual Consumer Growth ConferenceNYSE:GLSGelesis Holdings Inc
18/11/202220:00Business WireGelesis Receives Notice of NYSE Market Capitalization Listing Rule Non-ComplianceNYSE:GLSGelesis Holdings Inc
14/11/202209:00Business WireGelesis Reports Third Quarter 2022 ResultsNYSE:GLSGelesis Holdings Inc
07/11/202209:00Business WireGelesis to Report Third Quarter 2022 Financial Results on November 14, 2022NYSE:GLSGelesis Holdings Inc
04/11/202219:00Business WireGelesis Receives Notice of NYSE Trading Share Price Listing Rule Non-ComplianceNYSE:GLSGelesis Holdings Inc
02/11/202208:30Business WireData Presented at Obesity Week Demonstrate that Gelesis Investigational Clinical-Stage Oral Superabsorbent Hydrogel Gel-B Preferentially Enhances the Growth of Akkermansia muciniphila in Preclinical Models Compared to PrebioticsNYSE:GLSGelesis Holdings Inc
01/11/202218:24Business WireDr. Frank Greenway to Present Data from the LIGHT-UP Study with Gelesis’ Oral Hydrogel Treatment GS200 at Obesity WeekNYSE:GLSGelesis Holdings Inc
08/09/202208:00Business WireGelesis to Participate in the Jefferies Virtual Fitness & Wellness SummitNYSE:GLSGelesis Holdings Inc
25/08/202218:31Edgar (US Regulatory)Securities Registration Statement (s-1/a)NYSE:GLSGelesis Holdings Inc
25/08/202208:00Business WireClinical Data from the LIGHT-UP Study Presented at the International Congress of Endocrinology Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic SyndromeNYSE:GLSGelesis Holdings Inc
24/08/202217:04Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NYSE:GLSGelesis Holdings Inc
23/08/202209:42Edgar (US Regulatory)Securities Registration Statement (s-1)NYSE:GLSGelesis Holdings Inc
 Apresentando as notícias mais relevantes sobre:NYSE:GLS

Seu Histórico Recente

NASDAQ
WWACU
Worldwide Webb Acquisition
LSE
QK37
Morg.st.b.v 25
BOV
S2HO34Q
Shopify
NASDAQ
INAQ
Insight Acquisition
LSE
0MK6
Caisse Regionale De Cred...
USOTC
QEXXF
Quattro Exploration and ... (CE)
BOV
HGRE11
Cshg Real Estate Fundo I...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados